Get the Stockscreener App
16.48
2.47%
0.40
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $16.48, with a volume of 11.06M.
It is up +2.47% in the last 24 hours and down -12.68% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
See More
Previous Close:
$16.08
Open:
$16.17
24h Volume:
11.06M
Relative Volume:
0.43
Market Cap:
$31.66B
Revenue:
$15.14B
Net Income/Loss:
$1.42B
P/E Ratio:
22.39
EPS:
0.7361
Net Cash Flow:
$1.63B
1W Performance:
+4.75%
1M Performance:
-12.68%
6M Performance:
-24.35%
1Y Performance:
-23.47%
1-Day Range:
$16.06
$16.67
1-Week Range:
$15.60
$16.67
52-Week Range:
$15.47
$25.17
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
1 KENVUE WAY, SUMMIT
Compare KVUE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
16.50 | 30.86B | 15.14B | 1.42B | 1.63B | 0.7361 |
|
PG
Procter Gamble Co
|
150.42 | 352.69B | 84.28B | 16.07B | 14.05B | 6.5067 |
|
UL
Unilever Plc Adr
|
58.88 | 143.78B | 64.99B | 6.71B | 6.53B | 2.4355 |
|
CL
Colgate Palmolive Co
|
78.25 | 63.04B | 20.00B | 3.05B | 3.37B | 3.5578 |
|
KMB
Kimberly Clark Corp
|
119.92 | 39.69B | 18.88B | 2.38B | 2.10B | 7.2549 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-26-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Apr-10-25 | Initiated | Redburn Atlantic | Neutral |
| Mar-24-25 | Initiated | Evercore ISI | In-line |
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Is Kenvue Inc. stock a buy in volatile marketsEntry Point & Daily Oversold Bounce Ideas - newser.com
Chart based analysis of Kenvue Inc. trends2025 Valuation Update & Precise Buy Zone Tips - newser.com
Is Kenvue Inc. (J4D) stock a buy for dividend portfoliosStock Surge & Weekly High Return Stock Opportunities - newser.com
Kenvue Inc. $KVUE Shares Sold by Belpointe Asset Management LLC - MarketBeat
Comparing Kenvue Inc. in custom built stock radarsDay Trade & Free Verified High Yield Trade Plans - newser.com
Is Kenvue Inc. a candidate for recovery play2025 Price Targets & Weekly High Return Opportunities - newser.com
QRG Capital Management Inc. Buys 29,813 Shares of Kenvue Inc. $KVUE - MarketBeat
Donald Trump’s Tylenol Warning Makes Kenvue Stock (KVUE) an Opportunity in Disguise - TipRanks
Kenvue (KVUE): Exploring Valuation After Recent Share Price Weakness - Yahoo Finance
Kenvue’s SWOT analysis: stock faces Tylenol headwinds amid strategic shift - Investing.com
Kenvue (NYSE:KVUE) Price Target Lowered to $21.00 at Bank of America - MarketBeat
Moderately bullish activity in Kenvue Inc with shares down 0.59% - TipRanks
Kenvue Becomes Oversold - Nasdaq
How the Narrative Around Kenvue Is Shifting Amid Legal and Regulatory Headwinds - Yahoo Finance
UBS Adjusts Kenvue Price Target to $17 From $23, Maintains Neutral Rating - MarketScreener
Kenvue price target lowered to $17 from $23 at UBS - TipRanks
These Were the 5 Worst-Performing Stocks in the S&P 500 in September 2025 -- and One's Decline Can Be Tied to President Trump - The Motley Fool
Citigroup Adjusts Price Target on Kenvue to $17 From $20, Maintains Neutral Rating - MarketScreener
WESPAC Advisors LLC Invests $544,000 in Kenvue Inc. $KVUE - MarketBeat
Near 52-Week Low, Should You Buy Kenvue Stock? - The Globe and Mail
KLP Kapitalforvaltning AS Has $22.45 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Simplicity Wealth LLC Purchases Shares of 24,210 Kenvue Inc. $KVUE - MarketBeat
Did Trump’s Tylenol Pregnancy Warning Just Shift Kenvue's (KVUE) Brand Risk Profile? - simplywall.st
Kenvue’s (KVUE) Long-Term Value Creation and its Place in NYSE Dividend Stocks - MSN
Bullish flow in Kenvue Inc with shares up 3.22% - TipRanks
Options Corner: Despite Political Woes, Kenvue Can Still Make Tylenol Great Again - Sahm
Is Kenvue Inc. stock a buy before new product rolloutJuly 2025 Highlights & Low Risk Entry Point Tips - newser.com
Visual trend scoring systems applied to Kenvue Inc.Stop Loss & AI Driven Price Forecasts - newser.com
Kenvue Inc. $KVUE Shares Sold by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Why Is Kenvue Stock Falling, and Is It a Buying Opportunity? - The Motley Fool
What insider purchases suggest about Kenvue Inc. stockMarket Performance Summary & AI Powered Market Trend Analysis - newser.com
How strong is Kenvue Inc. stock earnings growth2025 Trading Volume Trends & AI Driven Stock Price Forecasts - newser.com
Why retail traders accumulate Kenvue Inc. stockJuly 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - newser.com
Will Kenvue Inc. stock outperform benchmarksTrade Risk Report & AI Enhanced Trade Execution Alerts - newser.com
Why analysts raise outlook for Kenvue Inc. (J4D) stockEarnings Overview Report & Accurate Technical Buy Alerts - newser.com
Why millennials buy Kenvue Inc. stockMarket Trend Review & Reliable Entry Point Alerts - newser.com
Litigation risks for Kenvue: focus shifts to U.S. appeals court - Investing.com
Is Kenvue Inc. stock near bottom after decline2025 Fundamental Recap & Real-Time Market Sentiment Alerts - newser.com
Assessing Kenvue (KVUE) Valuation: Is the Stock Priced for a Potential Turnaround? - simplywall.st
Market Movers: Metsera and Apple surge, Kenvue falters on Tylenol troubles - MSN
Truist Financial Corp Has $16.46 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Moody’s changes Kenvue outlook to negative amid operational challenges - Investing.com
Is Kenvue Inc. stock poised for growthTrend Reversal & AI Enhanced Execution Alerts - newser.com
Lawmakers dump Tylenol stock before autism controversy - Vermont Daily Chronicle
Goldman Sachs Sticks To Its Hold Rating For Kenvue, Inc. (KVUE) - Barchart.com
How Kenvue Inc. (J4D) stock performs in easing cycles2025 Short Interest & Real-Time Volume Triggers - newser.com
Barclays Lowers PT on Kenvue (KVUE) to $17 From $20, Keeps an Equal Weight Rating - Yahoo Finance
Is Kenvue Inc. stock among top earnings playsTrade Signal Summary & Consistent Profit Trade Alerts - newser.com
Is There an Opportunity in Kenvue After Recent 24% Share Price Drop? - simplywall.st
Cornell Pochily Investment Advisors Inc. Acquires 19,609 Shares of Kenvue Inc. $KVUE - MarketBeat
Is Kenvue Inc. meeting your algorithmic filter criteria2025 Top Decliners & Expert Approved Trade Ideas - newser.com
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.26%
1.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):